ConductScience.org, home

Paper3936557

Selective killing of carcinoma cells "in vitro" by lipophilic-cationic compounds: a cellular basis.

Lampidis TJ and 3 others. Biomed Pharmacother, 1985. Cited by 86 papers, by iCite.

Cite this record

ConductScience Library. Selective killing of carcinoma cells "in vitro" by lipophilic-cationic compounds: a cellular basis. Papers, record 3936557. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3936557

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Selective killing of carcinoma cells "in vitro" by lipophilic-cationic compounds: a cellular basis.
PubMed
Journal
Biomed Pharmacother
PubMed
Year
1985
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
86
iCite
Relative citation ratio, by iCite
2.43
iCite
Revised in PubMed
2012-11-15
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lampidis TJT J
2Hasin YY
3Weiss MJM J
4Chen LBL B

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Membrane PotentialsMajor topic
Onium CompoundsMajor topic
Organophosphorus CompoundsMajor topic
PhenazinesMajor topic
RhodaminesMajor topic
XanthenesMajor topic
Animals
Breast Neoplasms
Cell Line
Female
Haplorhini
HeLa Cells
Humans
Kidney
Marsupialia

Source PubMed

Download CSV of topics

Cited by27

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 86 citations.

PMIDTitleJournalYearIn PapersSource
40524980Triphenylphosphine-Based Mitochondrial Targeting Nanocarriers: Advancing Cancer Therapy.Clin Pharmacol2025https://conductscience.org/library/papers/40524980PubMed
39275091The ATTO 565 Dye and Its Applications in Microscopy.Molecules2024https://conductscience.org/library/papers/39275091PubMed
38116415A Neutral Flavin-Triphenylamine Probe for Mitochondrial Bioimaging under Different Microenvironments.ACS Med Chem Lett2023https://conductscience.org/library/papers/38116415PubMed
37888013Toxic Effects of Penetrating Cations.Membranes (Basel)2023https://conductscience.org/library/papers/37888013PubMed
36559149Mitochondrial Dysfunction: Pathophysiology and Mitochondria-Targeted Drug Delivery Approaches.Pharmaceutics2022https://conductscience.org/library/papers/36559149PubMed
34135584Novel Strategies for Disrupting Cancer-Cell Functions with Mitochondria-Targeted Antitumor Drug-Loaded Nanoformulations.Int J Nanomedicine2021https://conductscience.org/library/papers/34135584PubMed
33114695Mitocans Revisited: Mitochondrial Targeting as Efficient Anti-Cancer Therapy.Int J Mol Sci2020https://conductscience.org/library/papers/33114695PubMed
32705265Mechanistic investigations of antitumor activity of a Rhodamine B‑oleanolic acid derivative bioconjugate.Oncol Rep2020https://conductscience.org/library/papers/32705265PubMed
30505656Mitochondria-targeting drug conjugates for cytotoxic, anti-oxidizing and sensing purposes: current strategies and future perspectives.Acta Pharm Sin B2018https://conductscience.org/library/papers/30505656PubMed
30428319Mitochondria-Targeted Honokiol Confers a Striking Inhibitory Effect on Lung Cancer via Inhibiting Complex I Activity.iScience2018https://conductscience.org/library/papers/30428319PubMed
30174604Mitochondrial-Targeting Anticancer Agent Conjugates and Nanocarrier Systems for Cancer Treatment.Front Pharmacol2018https://conductscience.org/library/papers/30174604PubMed
28654243Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications.Chem Rev2017https://conductscience.org/library/papers/28654243PubMed
24622277Rosamines targeting the cancer oxidative phosphorylation pathway.PLoS One2014https://conductscience.org/library/papers/24622277PubMed
24518045Actively targeted in vivo multiplex detection of intrinsic cancer biomarkers using biocompatible SERS nanotags.Sci Rep2014https://conductscience.org/library/papers/24518045PubMed
24059469Tunable cytotoxicity of rhodamine 6G via anion variations.J Am Chem Soc2013https://conductscience.org/library/papers/24059469PubMed
23210516Effect of the prosthetic group on the pharmacologic properties of 18F-labeled rhodamine B, a potential myocardial perfusion agent for positron emission tomography (PET).J Med Chem2012https://conductscience.org/library/papers/23210516PubMed
22991065Role of cytokines in experimentally induced lung cancer and chemoprevention by COX-2 selective inhibitor, etoricoxib.Mol Cell Biochem2013https://conductscience.org/library/papers/22991065PubMed
20346876Biodistribution and stability studies of [18F]fluoroethylrhodamine B, a potential PET myocardial perfusion agent.Nucl Med Biol2010https://conductscience.org/library/papers/20346876PubMed
19995573Small mitochondria-targeting molecules as anti-cancer agents.Mol Aspects Med2010https://conductscience.org/library/papers/19995573PubMed
19783150Synthesis of fluorine-18 labeled rhodamine B: A potential PET myocardial perfusion imaging agent.Appl Radiat Isot2010https://conductscience.org/library/papers/19783150PubMed

See all 27 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3936557

GET https://conductscience.org/api/papers/v1/3936557/cited_by?page=2